Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3598122 B1
Publication typeGrant
Publication dateNov 23, 1982
Filing dateApr 1, 1969
Priority dateApr 1, 1969
Publication numberUS 3598122 B1, US 3598122B1, US-B1-3598122, US3598122 B1, US3598122B1
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet

US 3598122 B1
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3710795 *Sep 29, 1970Jan 16, 1973Alza CorpDrug-delivery device with stretched, rate-controlling membrane
US3731683 *Jun 4, 1971May 8, 1973Alza CorpBandage for the controlled metering of topical drugs to the skin
US3797494 *Aug 9, 1971Mar 19, 1974Alza CorpBandage for the administration of drug by controlled metering through microporous materials
US3807398 *Sep 19, 1972Apr 30, 1974B GruczaOcular implant
US3854480 *Jun 2, 1970Dec 17, 1974Alza CorpDrug-delivery system
US3896819 *Sep 30, 1971Jul 29, 1975Alza CorpIUD having a replenishing drug reservoir
US3951622 *Dec 4, 1974Apr 20, 1976Wilk Immanuel JTime release perfume method and device
US3960150 *Sep 15, 1975Jun 1, 1976Alza CorporationBioerodible ocular device
US3961628 *Apr 21, 1975Jun 8, 1976Alza CorporationOcular drug dispensing system
US3964482 *May 17, 1971Jun 22, 1976Alza CorporationDrug delivery device
US3981303 *Jul 31, 1975Sep 21, 1976Alza CorporationBioerodible ocular device
US3986510 *Aug 1, 1975Oct 19, 1976Alza CorporationBioerodible ocular device
US3993071 *Jul 24, 1975Nov 23, 1976Alza CorporationBioerodible ocular device
US3993072 *Oct 17, 1975Nov 23, 1976Alza CorporationMicroporous drug delivery device
US3993073 *Mar 3, 1975Nov 23, 1976Alza CorporationNovel drug delivery device
US3996934 *Aug 9, 1971Dec 14, 1976Alza CorporationMedical bandage
US4191743 *Nov 2, 1977Mar 4, 1980Merck Patent Gesellschaft Mit Beschrankter HaftungAntibacterial wound dressing
US4201211 *Jul 12, 1977May 6, 1980Alza CorporationTherapeutic system for administering clonidine transdermally
US4286592 *Feb 4, 1980Sep 1, 1981Alza CorporationTherapeutic system for administering drugs to the skin
US4336243 *May 4, 1981Jun 22, 1982G. D. Searle & Co.Transdermal nitroglycerin pad
US4460371 *Dec 20, 1982Jul 17, 1984Dennison Manufacturing CompanyMedical equipment for transdermal application
US4563184 *Oct 17, 1983Jan 7, 1986Bernard KorolSynthetic resin wound dressing and method of treatment using same
US4568343 *Oct 9, 1984Feb 4, 1986Alza CorporationSkin permeation enhancer compositions
US4594240 *Sep 7, 1983Jun 10, 1986Teikoku Seiyaku Kabushiki KaishaSheet-shape adhesive preparation
US4597961 *Jan 23, 1985Jul 1, 1986Etscorn Frank TTranscutaneous application of nicotine
US4608249 *Nov 2, 1982Aug 26, 1986Nitto Electric Industrial Co., Ltd.Carrier and drug containing patching layer
US4614787 *Nov 13, 1984Sep 30, 1986Thermedics, Inc.Drug dispensing wound dressing
US4615697 *Nov 9, 1984Oct 7, 1986Bio-Mimetics, Inc.Bioadhesive compositions and methods of treatment therewith
US4638043 *Aug 23, 1985Jan 20, 1987Thermedics, Inc.Drug release system
US4649075 *Aug 9, 1984Mar 10, 1987Leonora JostTransdermal and transmucosal vortexed foam devices and the method of making
US4666441 *Dec 17, 1985May 19, 1987Ciba-Geigy CorporationMulticompartmentalized transdermal patches
US4704282 *Jun 29, 1984Nov 3, 1987Alza CorporationSustained release
US4719226 *Dec 31, 1984Jan 12, 1988Nitto Electric Industrial Co., Ltd.Sustained drug release
US4725439 *Jan 13, 1986Feb 16, 1988Alza CorporationReinforced matrix containing drug reservoir
US4727868 *May 20, 1987Mar 1, 1988Thermedics, Inc.Anisotropic wound dressing
US4738848 *Jun 4, 1986Apr 19, 1988Nitto Electric Industrial Co., Ltd.Anti-inflammatory analgesic adhesive preparation
US4743249 *Jun 10, 1987May 10, 1988Ciba-Geigy Corp.Dermal and transdermal patches having a discontinuous pattern adhesive layer
US4746515 *Feb 26, 1987May 24, 1988Alza CorporationSkin permeation enhancer compositions using glycerol monolaurate
US4751133 *May 11, 1987Jun 14, 1988Thermedics, Inc.Medical patches and processes for producing same
US4752478 *Dec 17, 1984Jun 21, 1988Merck & Co., Inc.Transdermal system for timolol
US4764378 *Feb 10, 1986Aug 16, 1988Zetachron, Inc.Matrices of high and low molecular weight polyoxyethylene glycols
US4764379 *Aug 24, 1987Aug 16, 1988Alza CorporationTransdermal drug delivery device with dual permeation enhancers
US4767787 *Mar 24, 1986Aug 30, 1988Kaken Pharmaceutical Co., Ltd.Containing prostaglandin
US4769028 *Jul 17, 1986Sep 6, 1988Lohmann Gmbh & Co. KgMultilayer with drug concentration gradient
US4781924 *Nov 9, 1987Nov 1, 1988Alza CorporationRelease by moisture activator
US4788062 *Feb 26, 1987Nov 29, 1988Alza CorporationDispersion in polymer matrix, permeation promoter
US4795436 *Sep 22, 1986Jan 3, 1989Bio-Mimetics, Inc.Bioadhesive composition and method of treatment therewith
US4797284 *Mar 12, 1986Jan 10, 1989Merck & Co., Inc.Reservoir with permeable membrane
US4812305 *Nov 9, 1987Mar 14, 1989Vocal Rodolfo SWell medicine strip
US4816258 *Feb 26, 1987Mar 28, 1989Alza CorporationDrug delivery, ethylneestradiol, leyonorgestrel
US4820720 *Mar 29, 1988Apr 11, 1989Alza CorporationGlycerol monolaurate and ethanol enhancers;controlled drug delivery
US4834979 *Dec 14, 1987May 30, 1989Alza CorporationMedical bandage for administering beneficial drug
US4837027 *Aug 9, 1988Jun 6, 1989Alza CorporationTherapeutic agent stored as salt, moisture activates
US4839174 *Oct 5, 1987Jun 13, 1989Pharmetrix CorporationNovel transdermal nicotine patch
US4840796 *Apr 22, 1988Jun 20, 1989Dow Corning CorporationLinear thermoplastic polyurrethane polysiloxanne block coploym er
US4844903 *Nov 6, 1987Jul 4, 1989Mepha AgProcess for the production of an adhesive plaster
US4863738 *Nov 23, 1987Sep 5, 1989Alza CorporationTransdermal drug delivery
US4865848 *Feb 26, 1987Sep 12, 1989Alza CorporationSkin permeation enhancer compositions using sucrose esters
US4877618 *Mar 18, 1988Oct 31, 1989Reed Jr Fred DTransdermal drug delivery device
US4879275 *May 27, 1988Nov 7, 1989Nelson Research & Development Co.Penetration enhancers for transdermal delivery of systemic agent
US4880690 *Sep 9, 1988Nov 14, 1989Thermedics, Inc.Perfume patch
US4885154 *Mar 1, 1988Dec 5, 1989Alza CorporationCoadministering a metabolic modulator
US4889720 *Aug 31, 1987Dec 26, 1989Teikoku Seiyaku Kabushiki KaishaAdhesive, reservoir and control release layer
US4898592 *Sep 16, 1988Feb 6, 1990Latzke Arno WMeans for the application of transdermally absorbable active substances
US4900552 *Mar 30, 1988Feb 13, 1990Watson Laboratories, Inc.Mucoadhesive buccal dosage forms
US4900555 *Oct 13, 1988Feb 13, 1990Alza CorporationSkin permeation enhancer compositions using sucrose esters
US4906475 *Feb 16, 1988Mar 6, 1990Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US4908027 *Sep 12, 1986Mar 13, 1990Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US4909244 *Nov 26, 1986Mar 20, 1990The Kendall CompanyHydrogel wound dressing
US4917688 *Jun 27, 1988Apr 17, 1990Nelson Research & Development Co.Bandage for transdermal delivery of systemically-active drug
US4917895 *Jul 14, 1988Apr 17, 1990Alza CorporationTransdermal drug delivery device
US4920101 *Sep 30, 1987Apr 24, 1990Nelson Research & Development Co.For enhancing penetration of physiologically active agents through skin or other membranes
US4925671 *Jul 7, 1984May 15, 1990Flexcon Company, Inc.Polysiloxanes and nitroglycerin; transdermal
US4940586 *Oct 13, 1988Jul 10, 1990Alza CorporationSkin permeation enhancer compositions using sucrose esters
US4942037 *Jun 2, 1988Jul 17, 1990Merck & Co., Inc.Transdermal delivery systems
US4943435 *Oct 28, 1988Jul 24, 1990Pharmetrix CorporationTransdermal drug delivery, polyethylene membrane
US4951657 *Apr 22, 1988Aug 28, 1990Dow Corning CorporationBlock copolymer of polyurethane and polysiloxane
US4956171 *Jul 21, 1989Sep 11, 1990Paco Pharmaceutical Services, Inc.Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US4959208 *Oct 28, 1988Sep 25, 1990Ppg Industries, Inc.Active agent delivery device
US4969871 *Feb 15, 1989Nov 13, 1990Alza CorporationIntravenous system for delivering a beneficial agent
US4973468 *Mar 22, 1989Nov 27, 1990Cygnus Research CorporationSkin permeation enhancer compositions
US4979946 *Apr 7, 1989Dec 25, 1990The Kendall CompanyEnvironmental absorbent dressing
US4985016 *Feb 15, 1989Jan 15, 1991Alza CorporationIntravenous system for delivering a beneficial agent
US4994049 *Nov 15, 1989Feb 19, 1991Latzke Arno WApplication of transdermally active oil; absorptive carrier on laminate support
US4997655 *Jun 22, 1988Mar 5, 1991Biogal GyogyszergyarPharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
US5000956 *Jul 8, 1988Mar 19, 1991Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5004610 *Jun 14, 1990Apr 2, 1991Alza CorporationSubsaturated nicotine transdermal therapeutic system
US5034386 *Aug 17, 1988Jul 23, 1991Whitby Research, Inc.Fungicides
US5035886 *May 10, 1990Jul 30, 1991Ppg Industries, Inc.Active agent delivery device
US5045059 *Aug 15, 1990Sep 3, 1991Alza CorporationIntravenous system for delivering a beneficial agent
US5049387 *Jun 9, 1989Sep 17, 1991Alza CorporationInducing skin tolerance to a sensitizing drug
US5053227 *Jun 12, 1990Oct 1, 1991Cygnus Therapeutic SystemsTransmittance of drug in mixture of diethylene glycol ethyl and/or methyl ether and ester
US5059189 *Sep 8, 1987Oct 22, 1991E. R. Squibb & Sons, Inc.Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5059426 *Jun 12, 1990Oct 22, 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5068226 *Apr 30, 1990Nov 26, 1991Cyclex, Inc.Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US5071645 *Mar 20, 1991Dec 10, 1991Ppg Industries, Inc.Process of producing an active agent delivery device
US5071656 *Nov 14, 1988Dec 10, 1991Alza CorporationNitroglycerin delivery to skin or mucosa
US5077054 *Nov 27, 1990Dec 31, 1991Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5118509 *Aug 30, 1991Jun 2, 1992Alza CorporationInducing skin tolerance to a sensitizing drug
US5120545 *Aug 3, 1990Jun 9, 1992Alza CorporationSensitizing drug and antigen processing-inhibiting agent
US5124157 *Aug 18, 1989Jun 23, 1992Cygnus Therapeutic SystemsUsing adhesive skin patch
US5130139 *Jul 6, 1990Jul 14, 1992Alza CorporationCoadministering lysosomac uptake inhibiting agent
US5141750 *Nov 14, 1988Aug 25, 1992Alza CorporationDelayed onset transdermal delivery device
US5149539 *Nov 15, 1991Sep 22, 1992Alza CorporationReduction or prevention of sensitization to drugs
US5160320 *Feb 14, 1990Nov 3, 1992Alza CorporationIntravenous system for delivering a beneficial agent
US5160741 *Nov 13, 1991Nov 3, 1992Alza CorporationReduction or prevention of skin irritation by drugs
US5171576 *Aug 30, 1991Dec 15, 1992Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5173302 *Sep 28, 1990Dec 22, 1992Medtronic, Inc.2-acrylamido-2-methyl propanesulfonic acid copolymer, ethylene /propylene oxide derivative humectant, crosslinking monomer, initiator
US5189986 *Sep 23, 1991Mar 2, 1993Alza CorporationVeterinary transdermal active agent delivery device
US5196202 *Oct 2, 1989Mar 23, 1993Teikoku Seiyaku Kabushiki KaishaSustained release dosage form
US5198223 *Mar 9, 1992Mar 30, 1993Alza CorporationEstrogen/Progesterone, Skin Permeation Enhancer
US5203768 *Jul 24, 1991Apr 20, 1993Alza CorporationTransdermal delivery device
US5204339 *Aug 6, 1990Apr 20, 1993Whitby Research, Inc.Penetration enhancers for transdermal delivery of systemic agents
US5217718 *Sep 17, 1991Jun 8, 1993Cygnus Therapeutic SystemsUsing pressure sensitive adhesive skin patch
US5223261 *Dec 31, 1991Jun 29, 1993Riker Laboratories, Inc.Transdermal estradiol delivery system
US5230896 *Oct 12, 1989Jul 27, 1993Warner-Lambert CompanyTransdermal nicotine delivery system
US5234690 *Aug 23, 1991Aug 10, 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5250028 *Aug 9, 1991Oct 5, 1993Alza CorporationIntravenous system for delivering a beneficial agent using permeability enhancers
US5254346 *Feb 23, 1989Oct 19, 1993Tucker Mark JOcclusive body for administering a physiologically active substance
US5268179 *Feb 14, 1992Dec 7, 1993Ciba-Geigy CorporationUltrasonically sealed transdermal drug delivery systems
US5273755 *Aug 23, 1991Dec 28, 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5273756 *Aug 23, 1991Dec 28, 1993Cygnus Therapeutic SystemsA backing, a pressure-rupturable reservoir, adsorbent wick, drug-permeable polymer adhesive, an unplasticized microporous membrane, and a drug-permeable membrane
US5284660 *Aug 21, 1992Feb 8, 1994Alza CorporationDelayed onset transdermal delivery device
US5286491 *May 18, 1992Feb 15, 1994Alza CorporationAdministering over a predetermined period of time
US5286748 *Nov 27, 1991Feb 15, 1994Eby Iii George AAntirhinoviral medicine dispersed in sweet carrier as lozenge, troche or syrup
US5298257 *Mar 19, 1992Mar 29, 1994Elan Transdermal LimitedControlled transdermal nicotine delivery; anti-irritant
US5304379 *Nov 3, 1992Apr 19, 1994Alza CorporationA reservoir consists of tetracaine and metabolic modulator to inhibit monoamine oxidase enzyme
US5314694 *Mar 26, 1993May 24, 1994Alza CorporationTransdermal formulations, methods and devices
US5320850 *Feb 12, 1993Jun 14, 1994Alza CorporationTransdermal delivery of the gestogen ST-1435 and devices therefor
US5322695 *Aug 25, 1992Jun 21, 1994Hercon Laboratories CorporationMoisture-vapor-permeable dressing
US5342623 *Jun 18, 1993Aug 30, 1994Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US5364628 *Oct 22, 1993Nov 15, 1994Sandoz Ltd.Pharmaceutical compositions
US5364634 *Nov 8, 1991Nov 15, 1994Southwest Research InstituteMouths; drug delivery
US5376377 *Dec 17, 1992Dec 27, 1994Alza CorporationTransdermal contraceptive formulations, methods and devices
US5378730 *Dec 3, 1992Jan 3, 1995Alza CorporationPermeation enhancer comprising ethanol and monoglycerides
US5402777 *Jun 3, 1992Apr 4, 1995Alza CorporationMethods and devices for facilitated non-invasive oxygen monitoring
US5411740 *Feb 8, 1994May 2, 1995Alza CorporationTransdermal administration of oxybutynin
US5445607 *Oct 15, 1992Aug 29, 1995Theratech, Inc.Iontophoresis device and method using a rate-controlling electrically sensitive membrane
US5451407 *Jun 21, 1993Sep 19, 1995Alza CorporationReduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
US5464387 *Oct 27, 1994Nov 7, 1995Alza CorporationTransdermal delivery device
US5490415 *Apr 15, 1994Feb 13, 1996Pharmetrix CorporationDiffusion test apparatus and method
US5498417 *May 12, 1994Mar 12, 1996Coating Sciences, Inc.Transdermal delivery of appetite suppressant drug
US5500222 *Feb 15, 1995Mar 19, 1996Alza CorporationMixed with monoglyceride permeation enhancer
US5508038 *Apr 16, 1990Apr 16, 1996Alza CorporationDrug delivery patches having mixture of high and low molecular weight polymers as adhesives which dissolve active agents, free of plasticizers and tackifiers
US5508039 *Oct 16, 1992Apr 16, 1996Alza CorporationControlled transdermal administration of melatonin
US5512292 *Dec 21, 1994Apr 30, 1996Alza CorporationTransdermal contraceptive formulations methods and devices
US5536263 *Mar 30, 1994Jul 16, 1996Lectec CorporationPressure sensitive adhesive, hydrocolloidal gel matrix containing medication; sustained release
US5560922 *Jun 5, 1995Oct 1, 1996Rutgers, The State University Of New Jersey17-beta-estradiol skin patches; drug delivery
US5589192 *Dec 5, 1994Dec 31, 1996Lintec CorporationGel pharmaceutical formulation for local anesthesia
US5599554 *Mar 19, 1996Feb 4, 1997The Procter & Gamble CompanyTreatment of nicotine craving and/or smoking withdrawal symptoms
US5633008 *Aug 12, 1993May 27, 1997Osborne; James L.Method of administering nicotine transdermally
US5633009 *Nov 12, 1993May 27, 1997Sano CorporationTransdermal administration of azapirones
US5641504 *May 20, 1992Jun 24, 1997Alza CorporationTransdermal drug delivery
US5650165 *Nov 7, 1995Jul 22, 1997Nitto Denko CorporationPercutaneous absorption preparation
US5662925 *Apr 26, 1996Sep 2, 1997Theratech, Inc.For administering an active agent to the skin or mucosa of an individual
US5662928 *Apr 21, 1995Sep 2, 1997Ciba-Geigy CorporationMethod for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
US5691377 *Jul 14, 1994Nov 25, 1997University Of Maryland Eastern Shore And University Of Maryland College ParkUse of N-methyl-aspartic acid for enhancing growth and altering body composition
US5705186 *Jan 5, 1995Jan 6, 1998Lts Lohmann Therapie-Systeme GmbhPharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide
US5707663 *May 16, 1995Jan 13, 1998Alza CorporationSustained antiepileptic therapy
US5733255 *Oct 15, 1996Mar 31, 1998Novartis Finance CorporationThermopile powered transdermal drug delivery device
US5741510 *Apr 8, 1996Apr 21, 1998Lectec CorporationAdhesive patch for applying analgesic medication to the skin
US5747065 *Sep 29, 1994May 5, 1998Lee; Eun SooMonoglyceride/lactate ester permeation enhancer for oxybutynin
US5750137 *Sep 29, 1994May 12, 1998Taskovich; Lina TormenDrug delivery, permeability, glycerides and lactates
US5763425 *Jan 8, 1997Jun 9, 1998Gundersen Clinic, Ltd.Gastrointestinal toxicity side effect inhibition
US5770220 *Nov 23, 1994Jun 23, 1998Lts Lohmann Therapie Systeme GmbhActive substance-containing patch
US5785991 *Jun 7, 1995Jul 28, 1998Alza CorporationTransdermal drug delivery
US5788983 *Sep 14, 1992Aug 4, 1998Rutgers, The State University Of New JerseyTransdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5804214 *Jul 6, 1994Sep 8, 1998Cygnus, Inc.Nonsteroidal antiinflammatory agents, analgesics
US5817331 *Jun 7, 1995Oct 6, 1998Sano CorporationAbsorption; drug delivery device
US5820876 *Jun 6, 1995Oct 13, 1998Lts Lohmann Therapie-Systeme Gmbh & Co. KgButadiene-acrylonitrile-methyl acrylate terpolymer, paper, and aluminum sealing bag containing a nicotine patch
US5837280 *Jun 7, 1995Nov 17, 1998Sano CorporationTransdermal administration of azapirones
US5840327 *Aug 15, 1996Nov 24, 1998Alza CorporationTransdermal drug delivery device having enhanced adhesion
US5843468 *May 13, 1996Dec 1, 1998Alza CorporationSkin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5861170 *Mar 22, 1994Jan 19, 1999Lts Lohmann Therapie-Systeme Gmbh & Co. KgAcetylsalicyclic acid-containing transdermal application system for antithrombotic therapy
US5882674 *Jun 3, 1995Mar 16, 1999Lts Lohmann Therapie-Systeme GmbhTransdermal therapeutic system comprising active substances representing carbon monoxide sources
US5882676 *May 26, 1995Mar 16, 1999Alza CorporationSkin permeation enhancer compositions using acyl lactylates
US5895660 *Dec 6, 1994Apr 20, 1999Lts Lohmann Therapie-Systeme GmbhDeuterated active substances in transdermal application
US5900250 *Apr 30, 1998May 4, 1999Alza CorporationMonoglyceride/lactate ester permeation enhancer for oxybutnin
US5919478 *Jun 24, 1994Jul 6, 1999Alza CorporationIncorporating poly-N-vinyl amide in a transdermal system
US5942243 *May 12, 1998Aug 24, 1999Polytherapeutics, Inc.Mucoadhesive compositions for administration of biologically active agents to animal tissue
US5962011 *Jun 24, 1997Oct 5, 1999Schering-Plough Healthcare Products, Inc.The device is useful for treating lesions or abnormal skin features such as corns, warts, calluses, bunions, actinic keratoses and hard hyperkeratotic skin as is often found on the face, arms, legs or feet.
US5962013 *Aug 4, 1998Oct 5, 1999Cygnus, Inc.Monolithic matrix transdermal delivery system for administering molsidomine
US5980943 *Oct 21, 1997Nov 9, 1999Alza CorporationA time release dosage form comprising a semipermeable wall in contact with a therapeutic drug granules coated with polyoxyalkylene glycol
US6001390 *Dec 18, 1996Dec 14, 1999Alza CorporationFormulations for transdermal delivery of pergolide
US6007837 *Feb 3, 1999Dec 28, 1999Alza CorporationHeating device comprising drug-supersaturated first layer and drug-free second layer to cause controlled drug migration from first layer into second layer, rapidly cooling to yield supersaturated concentration of drug in both layers
US6068853 *Oct 13, 1995May 30, 2000Novartis CorporationTemporally controlled drug delivery systems
US6071896 *Mar 18, 1998Jun 6, 2000Gundersen Clinic, Ltd.Suppression of thromboxane levels by percutaneous administration of aspirin
US6096333 *Oct 8, 1997Aug 1, 2000Lectec CorporationMethod of forming adhesive patch for applying medication to the skin
US6096334 *Dec 14, 1998Aug 1, 2000Lectec CorporationAdhesive patch for applying medication to the skin and method
US6110499 *Jul 20, 1998Aug 29, 2000Alza CorporationPhenytoin therapy
US6126963 *Jun 6, 1995Oct 3, 2000Lts Lohmann Therapie-Systeme Gmbh & Co. KgBags for transdermal drug therapy
US6139868 *Jun 6, 1995Oct 31, 2000Lts Lohmann Therapie-Systeme Gmbh & Co. KgTransdermal therapeutic system, its use and production process
US6165497 *Mar 1, 1991Dec 26, 2000Alza CorporationSubsaturated nicotine transdermal therapeutic system
US6174545Feb 3, 1999Jan 16, 2001Alza CorporationDevice for the transdermal administration of testosterone through intact, non-scrotal skin over an administration period
US6203817Jun 5, 1998Mar 20, 2001Alza CorporationReduction of skin reactions caused by transdermal drug delivery
US6238700May 5, 1998May 29, 2001Alza CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US6264978Dec 16, 1992Jul 24, 2001Lts Lohmann Therapie-Systeme Gmbh & Co. KgTransdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis
US6264980Dec 18, 1995Jul 24, 2001Lts Lohmann Therapie-Systeme GmbhTransdermal resorption of active substances from supercooled masses of levulic acid
US6287598May 28, 1993Sep 11, 2001Alza CorporationMethod for providing sustained antiepileptic therapy
US6344211Nov 21, 2000Feb 5, 2002Lts Lohmann Therapie-Systeme GmbhReleasing drugs to skin having absorption-increasing auxiliary agents; antibiotics, antipyretics, analgesics, anticoagulants, antidiabetic, cardiotonic, antispasmodic, hypotensive, anticholinergenic, antyarrthythmic agents
US6348210Nov 10, 1999Feb 19, 2002Alza CorporationMethods for transdermal drug administration
US6440457May 27, 1993Aug 27, 2002Alza CorporationAdministering venlafaxine antidepressant time-release agent; sustained release
US6469227May 12, 2000Oct 22, 2002Lectec CorporationAntipruritic patch
US6512010Jul 14, 1997Jan 28, 2003Alza CorporationFormulations for the administration of fluoxetine
US6569448Oct 17, 1997May 27, 2003Alza CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US6572879Jun 7, 1995Jun 3, 2003Alza CorporationFormulations for transdermal delivery of pergolide
US6592892Aug 29, 2000Jul 15, 2003Tepha, Inc.Flushable disposable polymeric products
US6660295Sep 29, 1998Dec 9, 2003Alza CorporationA pouch containing (a) a transdermal drug delivery device comprising a drug reservoir layer positioned between a release liner and a backing alyer, one of the layer being non-occlusive, (b) oxybutynin as antioxidant and desiccant
US6699497Jul 23, 1999Mar 2, 2004Alza CorporationPermeation enhancer
US6960353Sep 29, 2003Nov 1, 2005Alza CorporationFormulations for the transdermal administration of fenoldopam
US7011844Nov 22, 2002Mar 14, 2006Alza CorporationFormulations for the administration of fluoxetine
US7063859Sep 18, 2002Jun 20, 2006Noven Pharmaceuticals, Inc.Barrier film lined backing layer composition and method for topical administration of active agents
US7094422Aug 20, 2003Aug 22, 2006Acrux Dds Pty Ltd.With dermal penetration enhancer, octyl salicylate
US7169409Sep 8, 2003Jan 30, 2007Alza CorporationHeating film or laminate of a transdermal delivery device which comprises a dispersion of liquid drug in a matrix immediately following film formation or lamination; maintaining heat; cooling
US7357891Jan 30, 2004Apr 15, 2008Monosol Rx, LlcProcess for making an ingestible film
US7425292Feb 14, 2002Sep 16, 2008Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US7553923Oct 26, 2007Jun 30, 2009Metabolix, Inc.Medical devices and applications of polyhydroxyalkanoate polymers
US7622136Jun 18, 2004Nov 24, 2009Alza CorporationTransparent transdermal nicotine delivery devices
US7641825Jul 29, 2005Jan 5, 2010Tepha, Inc.Method of making a polyhydroxyalkanoate filament
US7666337May 28, 2004Feb 23, 2010Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US7824588Apr 14, 2008Nov 2, 2010Monosol Rx, LlcWater degradation; controlled drying; digestible film containing water soluble polymer
US7833208 *Dec 29, 2004Nov 16, 2010Kimberly-Clark Worldwide, Inc.Multilayer absorbent article
US7883487Dec 18, 2008Feb 8, 2011Shantha Totada RTransdermal local anesthetic patch with injection port
US7910641Dec 14, 2006Mar 22, 2011Monosol Rx, LlcPH modulated films for delivery of actives
US7943683Oct 31, 2007May 17, 2011Tepha, Inc.Thin bioabsorbable materials; toughness, low modulus, tensile strength; tissue repair, drug delivery and support; solvent casting or melt extrusion continuous production
US7972618Sep 20, 2007Jul 5, 2011Monosol Rx, LlcAn edible water-soluble film is provided. The film includes at least one water-soluble polymer, and a foam reducing flavoring agent, wherein the film is free of added anti-foaming or defoaming agents.
US8017150Apr 22, 2008Sep 13, 2011Monosol Rx, LlcPolyether combined with hydrophilic cellulosic material; demonstrates non-self-aggregating, uniform heterogeneity; mucosally adhesive water soluble product containing analgesic opiate; preventing air pocket formation during production
US8017598May 16, 2007Sep 13, 2011Knopp Neurosciences, Inc.Compositions of R(+) and S(−) pramipexole and methods of using the same
US8026254Nov 10, 2009Sep 27, 2011Purdue Pharma, L.P.Therapeutic agents useful for treating pain
US8034270Apr 30, 2004Oct 11, 2011Tepha, Inc.Polyhydroxyalkanoate medical textiles and fibers
US8075911Aug 20, 2007Dec 13, 2011Alza CorporationTransparent transdermal nicotine delivery devices
US8084059Sep 15, 2006Dec 27, 2011Alza CorporationAntidepressant dosage form
US8084125Dec 11, 2009Dec 27, 2011Tepha, Inc.Non-curling polyhydroxyalkanoate sutures
US8153162Sep 27, 2006Apr 10, 2012Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US8182840Sep 27, 2006May 22, 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US8182841Sep 27, 2006May 22, 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US8187639Sep 27, 2006May 29, 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8235929Jul 9, 2009Aug 7, 2012Griffin Santea BMethod of treating pruritis
US8236288Jan 6, 2012Aug 7, 2012Skinmedica, Inc.Melanin modification compositions and methods of use
US8241662Dec 21, 2006Aug 14, 2012Watson Laboratories, Inc.Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
US8273361Sep 26, 2007Sep 25, 2012Infectious Disease Research InstituteGlucopyranosyl lipid adjuvant; toll-like receptors; saponins; kits
US8317762 *Nov 10, 2008Nov 27, 2012Nurman SalimSkin patch for absorbing toxins from the body
US8329734Jul 27, 2009Dec 11, 2012Afgin Pharma LlcTopical therapy for migraine
US8343512Oct 20, 2011Jan 1, 2013Infectious Disease Research InstituteTreatment of allergic conditions using a composition containing synthetic adjuvant
US8353888Oct 7, 2010Jan 15, 2013Kimberly-Clark Worldwide, Inc.Multilayer absorbent article
US8361272Jun 27, 2007Jan 29, 2013Ferring B.V.Polyurethane elastomers
US8361273Sep 6, 2012Jan 29, 2013Ferring B.V.Polyurethane elastomers
US8377979Dec 5, 2006Feb 19, 2013Taro Pharmaceuticals North America, Inc.Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
US8383149Sep 22, 2006Feb 26, 2013Alza CorporationHigh enhancer-loading polyacrylate formulation for transdermal applications
US8420126Apr 23, 2012Apr 16, 2013Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8440235Apr 23, 2012May 14, 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US8445474Aug 5, 2011May 21, 2013Knopp Neurosciences, Inc.Compositions of R(+) and S(−) pramipexole and methods of using the same
US8455009Apr 23, 2012Jun 4, 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US8460707Mar 26, 2012Jun 11, 2013Ferring B.V.Stabilised prostaglandin composition
US8460714Apr 3, 2012Jun 11, 2013Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US8475832Aug 7, 2009Jul 2, 2013Rb Pharmaceuticals LimitedSublingual and buccal film compositions
US8491934Jul 28, 2005Jul 23, 2013Ferring B.V.Stabilised prostaglandin composition
US8518926Dec 14, 2007Aug 27, 2013Knopp Neurosciences, Inc.Compositions and methods of using (R)-pramipexole
US8519148Mar 14, 2008Aug 27, 2013Knopp Neurosciences, Inc.Synthesis of chirally purified substituted benzothiazole diamines
US8524254Oct 15, 2007Sep 3, 2013Ferring B.V.Bioresorbable polymers
US8524695Mar 14, 2008Sep 3, 2013Knopp Neurosciences, Inc.Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US8557281Jul 13, 2010Oct 15, 2013Ferring B.V.Water-swellable polymers
US8574205 *Mar 12, 2008Nov 5, 2013Dbv TechnologiesDevice for the cutaneous application of substances
US8592424Jun 29, 2009Nov 26, 2013Afgin Pharma LlcTopical regional neuro-affective therapy
US8603514Jul 10, 2007Dec 10, 2013Monosol Rx, LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8609114Aug 30, 2012Dec 17, 2013Infectious Diesease Research InstituteMethods of using a vaccine composition containing synthetic adjuvant
US8614179Jul 17, 2009Dec 24, 2013E-Therapeutics PlcAntibacterial combination therapy for the treatment of gram positive bacterial infections
US8628798Aug 10, 2012Jan 14, 2014Ferring B.V.Water-swellable polymers
US8632800May 12, 2006Jan 21, 2014Alza CorporationMultilayer drug delivery system with barrier against reservoir material flow
US8652378Mar 29, 2013Feb 18, 2014Monosol Rx LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8663680Dec 5, 2011Mar 4, 2014Alza CorporationTransparent transdermal nicotine delivery devices
US8663687May 13, 2010Mar 4, 2014Monosol Rx, LlcFilm compositions for delivery of actives
US8685437Mar 26, 2009Apr 1, 2014Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8709482May 31, 2013Apr 29, 2014Ferring B.V.Stabilised prostaglandin composition
US8715715Oct 29, 2009May 6, 2014Nal Pharmaceuticals Ltd.Dosage form for insertion into the mouth
US8722064Jun 4, 2010May 13, 2014Infectious Disease Research InstituteSynthetic glucopyranosyl lipid adjuvants
US20110046578 *Mar 12, 2008Feb 24, 2011Biry Jean-FrancoisDevice for the cutaneous application of substances
US20120245538 *Dec 2, 2010Sep 27, 2012Michael HorstmannTransdermal Therapeutic System for the Administration of Peptides
USRE32991 *Jul 25, 1988Jul 18, 1989Thermedics, Inc.Drug dispensing wound dressing
USRE37934Feb 3, 2000Dec 10, 2002Lts Lohmann Therapie-Systeme AgTransdermal therapeutic system
USRE39588Oct 31, 1990Apr 24, 2007Alza CorporationDelays onset of drug administration; does not deliver an initial burst of drug, less likely to cause irritation; stabilizes an active drug by storing it within a transdermal therapeutic system, in form suitable for storage
DE2647581A1 *Oct 21, 1976Apr 27, 1978Henkel KgaaBlisterpackung
DE3500508A1 *Jan 9, 1985Sep 12, 1985Nitto Electric Ind CoPraeparat zur perkutanen verabreichung von arzneimitteln und verfahren zu dessen herstellung
DE3939703A1 *Dec 1, 1989Jun 6, 1991Boehringer Ingelheim KgVerbesserte transdermale applikation von pharmakologisch aktiven verbindungen
DE3939703C2 *Dec 1, 1989Jul 2, 1998Boehringer Ingelheim KgVerbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen
DE4421433C1 *Jun 18, 1994Jun 8, 1995Lohmann Therapie Syst LtsTransdermal therapeutic system for treatment of, e.g., hypertension
DE102013107024A1Jul 4, 2013May 15, 2014Golden Biotechnology CorporationMethoden und Zusammensetzungen zum Behandeln, Modifizieren und Handhaben von Knochenkrebsschmerz
DE102013202928A1Feb 22, 2013Aug 29, 2013Golden Biotechnology CorporationVerfahren und Zusammensetzungen zum Behandeln von Krebsmetastasierung
EP0065370A1 *Apr 29, 1982Nov 24, 1982Smith and Nephew Associated Companies p.l.c.Sterile dressing and preparation thereof
EP0236266A1 *Feb 9, 1987Sep 9, 1987Ciba-Geigy AgDermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof
EP0246385A1 *May 23, 1986Nov 25, 1987New Mexico Tech Research FoundationTranscutaneous application of nicotine
EP0249343A1 *May 14, 1987Dec 16, 1987Alza CorporationMoisture activation of transdermal drug delivery system
EP0249475A2 *Jun 11, 1987Dec 16, 1987Alza CorporationDelayed percutaneous delivery
EP0250125A2 *Jun 3, 1987Dec 23, 1987Smith & Nephew plcDrug delivery device, its preparation and use
EP0259136A2Sep 1, 1987Mar 9, 1988Alza CorporationTransdermal delivery device having a rate controlling adhesive
EP0273004A2 *Nov 16, 1987Jun 29, 1988Ciba-Geigy AgUser-activated therapeutical system
EP0279977A2 *Sep 28, 1987Aug 31, 1988Alza CorporationTransdermal administration of progesterone, estradiol esters and mixtures thereof
EP0336543A1 *Feb 23, 1989Oct 11, 1989John Mark TuckerOcclusive body for administering a physiologically active substance
EP0498468A1 *May 23, 1986Aug 12, 1992New Mexico Tech Research FoundationDevice for transcutaneous application of nicotine
EP1674068A1Feb 19, 1997Jun 28, 2006Acrux DDS Pty LtdDermal penetration enhancers and drug delivery systems involving same
EP2014282A2Jun 20, 2008Jan 14, 2009E-Therapeutics plcTreatment of depression
EP2158903A2Dec 14, 1999Mar 3, 2010ALZA CorporationTransparent Transdermal Nicotine Delivery Devices
EP2201840A1Dec 28, 2006Jun 30, 2010Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2308480A2Sep 22, 2006Apr 13, 2011ALZA CorporationHigh Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
EP2316437A1May 12, 2006May 4, 2011Alza CorporationMultilayer drug delivery system with barrier against reservoir material flow
EP2443929A1Dec 28, 2006Apr 25, 2012Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2508231A2Nov 15, 2007Oct 10, 2012E-Therapeutics PlcImidazoles for treating multi-drug resistant bacterial infections
EP2526771A1Dec 28, 2006Nov 28, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526933A2Dec 28, 2006Nov 28, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526934A2Dec 28, 2006Nov 28, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529621A1Dec 28, 2006Dec 5, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529622A1Dec 28, 2006Dec 5, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529733A1Jul 18, 2008Dec 5, 2012E-Therapeutics PlcAntibacterial combination therapy
EP2529737A1Jul 18, 2008Dec 5, 2012E-Therapeutics plcAntibacterial combination therapy
EP2530083A1Dec 28, 2006Dec 5, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532234A1Dec 28, 2006Dec 12, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532235A1Dec 28, 2006Dec 12, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2650294A1Oct 12, 2010Oct 16, 2013Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2664337A1Sep 27, 2006Nov 20, 2013TissueTech, Inc.Amniotic membrane preparations and purified compositions and methods of use
WO1986000532A1 *Jul 7, 1984Jan 30, 1986Flexcon Co IncSilicone pressure sensitive adhesive and uses
WO1987003477A1 *Dec 12, 1985Jun 18, 1987Flexcon Co IncTransdermal methods and adhesives
WO1989007959A1 *Feb 23, 1989Sep 8, 1989John Mark TuckerOcclusive body for administering a physiologically active substance
WO1991006270A1 *Oct 31, 1989May 16, 1991Watson Lab IncMucoadhesive buccal dosage forms
WO1993012799A1 *Dec 16, 1992Jul 8, 1993Lohmann Therapie Syst LtsTransdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
WO1994018966A1 *Feb 5, 1994Sep 1, 1994Fritz HerrmannTransdermal therapeutic system with active substances which represent sources of nitrogen oxide
WO1995035105A1 *Jun 3, 1995Dec 28, 1995Lohmann Therapie Syst LtsTransdermal therapeutic system with active substances constituting sources of carbon monoxide
WO2004105854A1 *Jun 3, 2004Dec 9, 2004Ilya KaplounDevice and method for dispensing medication to tissue lining a body cavity
WO2007035939A2Sep 22, 2006Mar 29, 2007Alza CorpHigh enhancer-loading polyacrylate formulation for transdermal applications
WO2007062266A2Nov 28, 2006May 31, 2007Marinus PharmaceuticalsGanaxolone formulations and methods for the making and use thereof
WO2008021368A2Aug 13, 2007Feb 21, 2008Norman HaugheyCompositions and methods for neuroprotection
WO2008066899A2Nov 28, 2007Jun 5, 2008Marinus PharmaceuticalsNanoparticulate formulations and methods for the making and use thereof
WO2009013480A2Jul 18, 2008Jan 29, 2009E Therapeutics PlcAntibacterial combination therapy
WO2010071866A2Dec 19, 2009Jun 24, 2010Nuon Therapeutics, Inc.Combination therapy for arthritis with tranilast
WO2011030106A1Sep 10, 2010Mar 17, 2011E-Therapeutics PlcCancer cell apoptosis
WO2012046006A2Oct 7, 2011Apr 12, 2012University Of DundeeCancer targets
WO2012104589A1Feb 2, 2012Aug 9, 2012University Of EdinburghWeight related disorders
WO2013160645A1Apr 26, 2013Oct 31, 2013E-Therapeutics PlcDexanabinol or a derivative thereof for use in the treatment of cancer in dose ranges of 2-30 mg/kg
WO2013164561A1May 3, 2013Nov 7, 2013E-Therapeutics PlcTramadol for treating depression
Classifications
International ClassificationA61L15/58, A61M31/00, A61L15/16, A61M37/00, A61F9/00, A61K9/70
Cooperative ClassificationA61F9/0017, A61M31/002, A61K9/7084, A61M37/00, A61L15/58
European ClassificationA61F9/00B2, A61M31/00D, A61M37/00, A61L15/58, A61K9/70E2D
Legal Events
DateCodeEventDescription
Nov 23, 1982B1Reexamination certificate first reexamination